FDA Inspection
McKesson Corporation dba RxPakMcKesson Corporation dba RxPak – FDA Inspection, Mar 22, 2018
Record Details
This FDA Inspection record concerns McKesson Corporation dba RxPak, with an inspection on March 22, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 95128efc-57ed-4764-b2ee-a98c44065eae
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1046405
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.84(b)Representative Samples
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of McKesson Corporation dba RxPak
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 27, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 1, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for McKesson Corporation dba RxPak
- FDA Inspection 984729 - 2016-07-27
- FDA Inspection 650331 - 2010-03-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.